3 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
| Phase 2 | 1 | Terminated 1 |
Follow emvododstat: new trials by email Literature Review of emvododstat trials Research Report on emvododstat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias PTC299 - Leukemia, Myeloid, Acute, AML | Phase 1 | Terminated | PTC Therapeutics | 33 | 2018-10-29 | 2022-02-02 |
| PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma VEGF inhibitor PTC299, gene expression analysis, polymerase chain reaction - Kaposi's Sarcoma | Phase 1 / Phase 2 | Terminated | AIDS Malignancy Consortium | 17 | 2008-09-01 | 2018-06-06 |
| PTC299 for Treatment of Advanced Cancer PTC299, Docetaxel - Advanced Cancer | Phase 1 | Terminated | PTC Therapeutics | 76 | 2008-07-03 | 2019-05-10 |
Neoplasms (2) · AIDS-related Kaposi sarcoma (1) · HIV Infections (1) · Leukemia, Myeloid (1) · Leukemia, Myeloid, Acute (1) · Neoplasms by Histologic Type (1) · Sarcoma, Kaposi (1)
PTC Therapeutics (2) · AIDS Malignancy Consortium (1)
United States (3)
Gary Schwartz, MD (1) · Susan E. Krown, MD (1)
U01CA121947 (1)